# History and Physical

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Duke Kahanamoku (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML050-SYN
- Date: 2026-03-16
- Fictional facility: St. Posthumous Health Center
- Fictional author: Kawika Lindgren-Morrison, MD
- Calendar frame: modern shifted

## Reason for visit

Establishing care for six weeks of breathlessness, ankle swelling and tiredness five years after a heart attack: examination, ECG, chest X-ray, NT-proBNP and laboratory tests, a diuretic, and the plan for an echocardiogram. **S**

## Historical basis

- Duke Kahanamoku was born on August 24, 1890, in Honolulu, at Haleʻākala, the Honolulu home of Princess Bernice Pauahi Bishop; he was named after his father, who had been named Duke for a visit of the Duke of Edinburgh to Hawaiʻi. **D**
- Olympedia gives his full name as Duke Paoa Kahino Makoe Hulikohoa Kahanamoku. **D**
- He won the Olympic 100-meter freestyle in 1912 at Stockholm (with silver in the 4 x 200-meter relay) and again in 1920 at Antwerp (with gold in the relay), and silver in the 100-meter freestyle in 1924 at Paris: three gold and two silver medals. **D**
- He co-founded the Hui Nalu surf club in 1911, introduced surfing to the Atlantic coast of the United States in 1914 and gave a surfing exhibition at Freshwater Beach in Sydney on December 24, 1914, widely regarded as a seminal event for surfing in Australia; he was inducted into the International Swimming Hall of Fame in 1965 and was the first inductee of the International Surfing Hall of Fame in 1966. **D**
- From 1922 he lived in Los Angeles for years and found small roles in many Hollywood films. **D**
- He was elected sheriff of Honolulu for 13 consecutive terms, from 1934 until the post was eliminated in 1960, after which he was named Hawaiʻi's "Ambassador of Aloha"; other sources date his first election to 1932 and his departure to 1961. **D**
- He married Nadine Alexander on August 2, 1940, in Kailua-Kona. **D**
- He never drank alcohol or smoked and trained consistently. **D**
- He had a heart attack in 1952 and suffered several heart attacks in his later years, continuing to swim and sail almost to the end of his life. **D**
- He had no great personal wealth. **D**
- He was the official United States representative at the 1956 Melbourne Olympic Games. **D**

3 later historical claims are omitted because they describe events after the index age. See the teaching note.

These claims are historical evidence, not findings from a real modern examination.

## History of present illness

This fictional modern episode addresses the presenting concerns below. **S**

- He wants to get back in the ocean, to swim and surf again. **S**
- He wants to keep working as sheriff. **S**
- He wants his ʻohana involved as he chooses and his own ways of healing respected. **S**

## Strengths and supports

- Engagement in care and meaningful activity **S**

## Medications and allergies

- Aspirin 81 mg delayed-release oral tablet, one tablet daily **S**
- Atorvastatin 40 mg oral tablet, one tablet daily **S**
- Atorvastatin 80 mg oral tablet, one tablet daily **S**
- Metoprolol tartrate 25 mg oral tablet, one tablet twice daily **S**
- Lisinopril 10 mg oral tablet, one tablet daily **S**
- Furosemide 40 mg oral tablet, one tablet every morning **S**
- No known allergy **S**

## Past medical history

True biography with historical dates; these events are not part of the synthetic care timeline.

- 1952: Heart attack in 1952, at about 61, one of several in his later years; details of its treatment are not recorded in the sources read **D** (CLM-0009)

## Procedures and immunizations

- 2026-03-16 to 2026-03-16: Twelve-lead electrocardiogram: sinus rhythm at 92 per minute, Q waves in V1 to V4 from an old anterior infarction, QRS 104 ms, no left bundle branch block, no atrial fibrillation **S**
- 2026-03-16 to 2026-03-16: Chest X-ray, two views: enlarged heart, upper-lobe venous diversion and small pleural effusions on both sides; no pneumonia **S**


## Family history

- No family medical history is documented in the logged sources. Family history of real relatives is never synthesized.

## Measurements

NT-proBNP: 2450 pg/mL (high); Sodium: 138 mmol/L; Potassium: 4.2 mmol/L; Creatinine: 1.02 mg/dL; eGFR (CKD-EPI 2021): 81 mL/min/1.73 m²; Glucose: 102 mg/dL (high); Magnesium: 2 mg/dL; Hemoglobin: 13.4 g/dL; Ferritin: 62 ng/mL (low); Transferrin saturation: 16% (low); TSH: 2.1 mIU/L; Hemoglobin A1c: 5.9% (high); Total cholesterol: 168 mg/dL; LDL cholesterol: 92 mg/dL (high); HDL cholesterol: 44 mg/dL; Triglycerides: 160 mg/dL (high); ALT: 28 U/L; PHQ-2: 1; KCCQ-12 overall summary: 38. All results are synthetic.

BP 142/86 mmHg; pulse 92 bpm; respirations 20/min; temperature 36.7 °C; oxygen saturation 94% on room air; weight 97.6 kg; BMI 28.5 kg/m². All vital signs are synthetic.

## Examination

Mental status: Alert, calm and courteous; frustrated at being kept from the water; mood steady; PHQ-2 score 1. Functional status: Independent in all daily activities; breathless walking up a gentle slope or paddling out through small surf; has stopped his morning swim after a few minutes; sleeps on two pillows; NYHA class III. Physical examination is intentionally limited. **S**

## Assessment

1. Breathlessness on exertion for six weeks (paddling out, walking uphill, finishing his morning swim), with ankle swelling by evening and tiredness, five years after a heart attack; cause to be determined; status draft. **S**
2. Coronary artery disease with an old anterior myocardial infarction five years ago, treated with medicines; synthetic modern episode linked to the documented heart attack of 1952; status draft. **S**
3. Iron deficiency without anemia (ferritin 62 ng/mL, transferrin saturation 16%); status draft. **S**

## Plan

- Culturally safe care: address him as Mr. Kahanamoku, as he asked; take time; explain each test and medicine plainly; involve his ʻohana as he chooses while he makes the decisions. Guideline: Potentially Preventable Hospitalizations for Congestive Heart Failure Among Asian Americans and Pacific Islanders in Hawaiʻi (2015); Ke Ola Mamo: a Native Hawaiian Health Care System serving Oʻahu (medical care, lomilomi and community health workers) (2026) **S**
- Heart failure cardiology consultation on the day of the two-week visit, with an echocardiogram, to confirm the diagnosis and its cause and to plan guideline-directed medical therapy, ischemic evaluation and device decisions. Guideline: 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure (2022); 2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction (2024); CMID: Clinical Monitoring Intelligence Database, heart failure and ischemic heart disease monographs (2026) **S**
- Furosemide 40 mg every morning for congestion, with a daily weight and a written plan; metabolic panel and magnesium in one to two weeks; lower the dose when he is dry. Guideline: 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure (2022); CMID: Clinical Monitoring Intelligence Database, heart failure and ischemic heart disease monographs (2026) **S**
- Baseline tests: ECG, chest X-ray, NT-proBNP, metabolic panel and magnesium, blood count, iron studies, TSH, hemoglobin A1c, lipids and ALT; echocardiogram at the two-week visit. Guideline: 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure (2022); CMID: Clinical Monitoring Intelligence Database, heart failure and ischemic heart disease monographs (2026) **S**
- Atorvastatin raised from 40 to 80 mg for LDL 92 mg/dL; lipid panel in four to twelve weeks; goal below 70 mg/dL. Guideline: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (2023); CMID: Clinical Monitoring Intelligence Database, heart failure and ischemic heart disease monographs (2026) **S**
- Sodium: less salted and dried fish, shoyu and salty party food, using the foods he already eats; no routine fluid restriction; daily weights. Guideline: 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure (2022) **S**
- Vaccinations: pneumococcal, influenza, COVID-19 and RSV as due, because heart disease raises the risk of severe respiratory infection. Guideline: 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure (2022); Adult Immunization Schedule by Age (2026) **S**
- Native Hawaiian healing alongside clinic care, if he wishes: lomilomi through Ke Ola Mamo, a Native Hawaiian Health Care System; he will tell the clinic before using any plant medicine so that interactions can be checked; the clinic asks nothing further about his practices. Guideline: Ke Ola Mamo: a Native Hawaiian Health Care System serving Oʻahu (medical care, lomilomi and community health workers) (2026) **S**

## Guideline basis

- 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure (2022), American Heart Association, American College of Cardiology, and Heart Failure Society of America (Circulation 2022;145(18):e895-e1032)
- 2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction (2024), American College of Cardiology (J Am Coll Cardiol 2024;83(15):1444-1488)
- 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (2023), American Heart Association and American College of Cardiology (Circulation 2023;148(9):e9-e119)
- CMID: Clinical Monitoring Intelligence Database, heart failure and ischemic heart disease monographs (2026), Aether Forge
- Potentially Preventable Hospitalizations for Congestive Heart Failure Among Asian Americans and Pacific Islanders in Hawaiʻi (2015), Journal of Immigrant and Minority Health 2015;17(5):1289-1297
- Ke Ola Mamo: a Native Hawaiian Health Care System serving Oʻahu (medical care, lomilomi and community health workers) (2026), Ke Ola Mamo
- Adult Immunization Schedule by Age (2026), Centers for Disease Control and Prevention
